TELMIKIND AMH (Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg))

Telmikind-AMH Tablet is a formulation that combines multiple medications aimed at managing hypertension, or high blood pressure, especially when monotherapy is insufficient. The primary function of this tablet is to effectively reduce elevated blood pressure levels, thereby decreasing the likelihood of serious cardiovascular events such as heart attacks and strokes. The recommended administration can be done with or without food, but consistency in timing is beneficial for optimal results. It is crucial to adhere to the prescribed regimen unless directed otherwise by a healthcare professional. As this medication includes a diuretic component, it may result in increased urination; thus, it is advisable to avoid taking it within four hours prior to bedtime. This treatment should be maintained consistently to ensure maximum efficacy, even in the absence of symptoms, as high blood pressure often presents with no noticeable indicators. Discontinuing use may elevate the risk of serious complications. Side effects may include dizziness, headaches, fatigue, alterations in taste, flu-like symptoms, diarrhea, and sinusitis, among others. Staying adequately hydrated is important to mitigate potential side effects such as muscle weakness and excessive thirst. Prior to starting this medication, individuals should disclose any pre-existing kidney or liver issues to their healthcare provider. Pregnant or nursing women should seek medical guidance before initiating treatment.